ArticleScientific reports2026
Baseline characteristics associated with mortality among children living with HIV initiating ART at a rural district HIV clinic of Mozambique.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study describes the incidence and factors associated with mortality in children living with HIV and initiating ART at rural settings. We analyzed routinely collected data from electronic medical records of children, aged under 15 years or younger, living with HIV (CLHIV) who were routinely managed at Carmelo Hospital of Chokwe, from 2002 to 2019, located in the Chokwe district, Gaza province, Mozambique. Kaplan-Meier survival curves and Cox regression analyzes were used to model the time to death and predictors of mortality respectively. Overall, 1341 HIV-infected children on ART contributed to a total number of 6705 child-years of observation. The overall death rate was 2.8 per 100 child-years. Cox regression predicted a higher risk of death among children aged 2 years or below (adjusted hazard ratio [aHR] 3.34, 95% confidence interval [CI] 1.46–3.74; p < 0.001), in inpatient CLHIV (aHR 1.88, 95% CI 1.19–2.97, p = 0.007), patients with WHO clinical stage III and IV disease (aHR 2.05, 95% CI 1.19–3.55, p = 0.010; aHR 4.30, 95% CI % 2.27–8.17, p < 0.001), having CD4 counts under 100 cells/µL (aHR 3.67, 95% CI 2.51–5.35, p < 0.001), receiving anti-TB treatment within 90 days of ART initiation (aHR 1.84, 95% CI 1.16–2.93, p = 0.010). Kaplan-Meier analysis showed higher cumulative incidence of mortality after 4 years of follow-up, above 70% in inpatient CLHIV, 54% of those that received ATT within 90 days of ART initiation, and 35% with CD4 < 100 cells/µL (log Rank test p < 0.0001). Reducing morbidity and mortality in this vulnerable group of patients requires a concerted effort to educate care workers on the guidelines for the management of advanced pediatric HIV Disease. Emphasis should be placed on early identification of CLHIV with lower CD4 cell counts, and screening for asymptomatic opportunistic infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.